Research Reports

Healthcare

icon
icon
Home » Reports » Diabetes Care Devices Market
Market Research Report

Diabetes Care Devices Market Segmentation By Product (Blood Glucose Monitoring Devices and Insulin Delivery Devices) - Global Demand Analysis & Opportunity Outlook 2027

Published On : December, 2018 REP-ID-836 Category: Healthcare

Product Overview

Diabetes is a disease in which pancreas are not able to produce required insulin in the body. The uncontrolled diabetes results in the increase of the blood glucose. The diabetes care devices are especially used to diagnose the diabetes. The diabetes care devices are used to facilitate the required amount of insulin in the body. It is primarily used to check the level of glucose in the body. It uses blood sugar meters and strips in order to monitor the glucose level. The diabetes care devices are small in size and also portable.

Market Size and Forecast

The global diabetes care devices market is anticipated to expand at a CAGR around 6.0% during 2018-2027. It is expected to reach significant market size by 2027. The rising obese population coupled with lifestyle problem is the major factor anticipated to increase the market growth of the global diabetes care devices market during the forecast period. The global diabetes care devices market can be segmented on the basis of product and region. On the basis of the product, it is sub-segmented into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring devices is anticipated to be the leading sub-segment of the product segment. The increasing use of the self-monitoring glucose devices across the globe is anticipated to boost the demand for the diabetes care devices during the forecast period. On the basis of blood glucose monitoring devices, global diabetes care devices market is again sub-segmented into testing strips, self-monitoring blood glucose meters, lancets and continuous blood glucose monitoring devices. The rising cases of the diabetes in the geriatric population coupled with technological advancement in the continuous blood glucose monitoring devices are also a reason for the sub-segment to lead the segment. On the basis of insulin delivery pipes, it is sub-segmented into insulin pumps, insulin syringes, insulin pens and insulin jet injectors.

By region, global diabetes care devices market is segmented into North America, Asia-Pacific, Latin America, Europe, Middle East and Africa. North America is anticipated to lead the global diabetes care devices market throughout the forecast period. The increasing number of diabetic patients coupled with highly developed healthcare infrastructure is anticipated to boost the demand for the diabetes care devices in the region. Additionally, the increasing research and development in blood glucose monitoring devices and presence of the key market players in the region is also major factor for the region to lead the global diabetes care devices market. Asia-Pacific region is anticipated to be the fastest developing region for the global diabetes care devices market. The growing population in the region coupled with increasing health awareness is anticipated to drive the market growth in the region. Additionally, the government is also taking various initiatives in order to promote awareness among the population regarding diabetes.

Market Segmentation

Our in-depth analysis segmented the global diabetes care devices market in the following segments:

By Product:

  • Blood Glucose Monitoring Devices 
    • Testing Strips
    • Self-monitoring Blood Glucose Meters
    • Lancets
    • Continuous Blood Glucose Monitoring Devices
  • Insulin Delivery Devices 
    • Insulin Pumps
    • Insulin Syringes
    • Insulin Pens
    • Insulin Jet Injectors

By Region

Global diabetes care devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Turkey Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (GCC, Israel, North Africa, South Africa, Rest of Middle East) Market size, Y-O-Y growth & Opportunity Analysis.

Diabetes Care Devices Market Graph

Growth Drivers and Challenges

The increasing incidence of diabetes among the growing population across the globe is anticipated to be the major growth driver for the global diabetes care devices market during the forecast period. The increasing lifestyle problem on the account of growing urbanization is anticipated to increase the demand for the diabetes care devices. The growing disposable income of the population is also anticipated to boost the global diabetes care devices market during the forecast period. The increasing awareness regarding the diabetes among the growing population is also anticipated to support the market growth of diabetes care devices market during the forecast period. The increasing technological advancement in the blood glucose monitoring devices is anticipated to provide key opportunities to the market players to establish themselves in the market. The developing healthcare industry across the various regions is also anticipated to be the major growth driver for the global diabetes care devices market.

However, high cost related to diabetes care devices is anticipated to be major restrain for the global diabetes care devices market during the forecast period.

Key Players

  • Dickinson and Company
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Becton
  • Johnson & Johnson
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd
  • Novo Nordisk A/S
  • Medtronic plc
  • Terumo Corporation

things to know

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

RELATED REPORTS

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com


UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Subscribe To Our Newsletters

Copyright © 2018 Research Nester. All rights reserved

Top